Circulating tumor DNA (ctDNA) analysis guiding adjuvant therapy in patients (pts) with colorectal cancer (CRC): Impact on fear of cancer recurrence (FCR).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sue-Anne McLachlan, Rodela Mostafa, Louise Sharpe, Matthew E. Burge, Fiona Day, Robert helmut Blum, Robert Campbell, James F. Lynam, Belinda Lee, Madhu Sudan Singh, Margaret Lee, Lorraine A. Chantrill, Joanne Lundy, Zee Wan Wong, Rachel Wong, Sachin Joshi, Ayesha Saqib, Deme John Karikios, Peter Gibbs, Jeanne Tie
Institutions: St Vincent's Hospital Melbourne, The University of Sydney, Royal Brisbane and Women's Hospital, Calvary Mater Newcastle Hospital, Bendigo Health, The University of Melbourne, Northern Health, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre, Eastern Health, Western Health, Shoalhaven District Memorial Hospital, Monash Health, Latrobe Regional Hospital, Epworth Hospital, Nepean Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410812396